Home / Formulary / AOD-9604

Back to formulary

LORIUM · 5 mg LYOPHILISED VIAL

Third-party tested · COA included with every lot

Metabolic ● In stockPrescription required

AOD-9604

Name: AOD-9604
Brand: LORIUM
SKU: aod-9604
Availability: InStock

GH fragment

AOD-9604 is a premium, structurally modified fragment of human growth hormone engineered exclusively to target adipose tissue metabolism and enhance lipid breakdown. By stimulating lipolysis without activating growth pathways or altering IGF-1 levels, this advanced protocol offers an exceptionally safe approach to body composition refinement and localized fat management.

$149 / month · 5 mg

Request through a provider Start intake to prescribe

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. It is dispensed only pursuant to a valid prescription following evaluation by a licensed provider.

Researched effects

Effects observed in the cited literature. Individual results are not guaranteed. Statements have not been evaluated by the FDA.

Targeted Adipose Reduction

Actively accelerates fat breakdown in stubborn areas like the abdomen and thighs.

Direct Fat Metabolism

Promotes lipid oxidation and breakdown independently of appetite regulation.

No Growth-Factor Elevation

Zero influence on growth hormone receptors, preventing any pro-diabetic side effects.

Glycemic Neutrality

Functions seamlessly without negatively impacting insulin sensitivity or carbohydrate metabolism.

Lean Mass Preservation

Targets subcutaneous fat loss while fully preserving valuable lean muscle tissue layers.

Premium Safety & Tolerability

Studied safety profile completely comparable to placebo in human settings.

Low Immunogenicity

Formulated for high biocompatibility, showing zero antibody formation during extended protocols.

Specifications

ClassGH fragment

CAS number221231-10-3

Molar mass1815.1 g/mol

Available sizes5 mg

AdministrationAdvanced subcutaneous protocol for metabolic refinement.

CategoryMetabolic

View a sample certificate of analysis →

Clinical references

Ng, F.M., et al. (2000). Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone. Hormone Research, 53(6), 274-278.
Stier, H., et al. (2013). Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans. Journal of Endocrinology and Metabolism, 3(1-2), 7-15.
Moré, M.I., et al. (2014). Safety and Metabolism of AOD9604, a Novel Nutraceutical Ingredient for Improved Metabolic Health. Journal of Endocrinology and Metabolism, 4(3), 64-77.
Heffernan, M.A., et al. (2001). The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)AR knock-out mice. Endocrinology, 142(12), 5182-5189.